Forte Biosciences, Inc. (FBRX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Forte Biosciences, Inc. (FBRX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

FBRX Cash Flow Statement

Forte Biosciences, Inc. (FBRX) cash flow statement — 11-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-22.7M	-18.81M	-16.47M	-14M	-10.06M	-10.36M	-10.01M	-8.13M	-5.94M	-6.67M	-8.97M	-9.06M	-5.47M	-5.2M	-2.89M	-1.94M	-1.38M	-1.98M	-3.58M	-5.13M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-125.64%	-81.63%	-64.51%	-72.14%	-69.49%	-55.32%	-11.6%	10.21%	-8.42%	-28.11%	-210.02%	-366.91%	-297.6%	-163.49%	19.24%	62.16%	65.03%	50.99%	5.81%	33.75%
Net Income	-23.33M	-22.14M	-24.79M	-17.68M	-11.25M	-15.66M	-7.16M	-8.39M	-12.51M	-7.42M	-5.87M	-9.96M	-8.9M	-6.75M	-4.88M	-3.4M	-3.04M	-2.57M	-3.34M	-7.75M
Depreciation & Amortization	20K	19K	19K	17K	15K	13K	10K	10K	10K	9K	6K	3K	0	0	0	0	0	0	0	9K
Stock-Based Compensation	0	3.18M	1.66M	1.48M	1.5M	1.62M	697K	791K	802K	805K	780K	772K	855K	877K	860K	906K	1.19M	1.05M	1.24M	1.47M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	2.63M	-7K	1.05M	-6K	0	-240K	-156K	9K	-5K	-6K	8K	-118K	-21K	0	0	0	0	0	0	61K
Working Capital Changes	-2.02M	139K	5.59M	2.19M	-322K	3.91M	-3.4M	-551K	5.77M	-55K	-3.89M	240K	2.59M	672K	1.12M	554K	464K	-463K	-1.48M	1.08M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	388K	3.1M	4.5M	558K	-90K	578K	-714K	-116K	3.59M	261K	-3.87M	2.28M	1.66M	189K	18K	466K	93K	-370K	-1.38M	1.34M
Cash from Investing	-147.84M	0	0	-55K	0	36.29M	-35.99M	0	0	-6K	-16K	10.03M	-9.96M	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	-55K	0	-61K	-31K	0	0	-6K	-17K	-71K	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	-9.96K	0	0	0	0	0	0	0
Cash from Financing	161.95M	74K	9K	1.32M	70.35M	-2.32M	51.88M	-2K	-10K	-8K	-75K	24.78M	-24K	6K	-55K	7.44M	-110K	-34K	-39K	-3K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	161.96M	101K	15K	1.33M	70.35M	-2.31M	53M	5K	-10K	8K	-64K	24.82M	-24K	6K	-55K	7.28M	0	12K	1K	19K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	-2K	-1K	-10K	0	0	0	-24	0	0	0	0	0	0	0
Other Financing	-11K	-27K	-6K	-5K	-3K	-15K	-1.12M	-7K	0	-16K	-11K	-48K	0	0	0	156K	-110K	-46K	-40K	-22K
Net Change in Cash	-8.59M	-18.73M	-16.46M	-12.73M	60.29M	23.61M	5.88M	-8.13M	-5.95M	-1.33M	-9.06M	706K	-15.46M	-5.2M	-2.95M	5.5M	-1.49M	-2.01M	-3.62M	-5.13M
Free Cash Flow	-22.7M	-18.81M	-16.47M	-14.05M	-10.06M	-10.42M	-10.04M	-8.13M	-5.94M	-6.67M	-8.99M	-9.13M	-5.47M	-5.2M	-2.89M	-1.94M	-1.38M	-1.98M	-3.58M	-5.13M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-125.64%	-80.57%	-64%	-72.81%	-69.49%	-56.09%	-11.73%	10.91%	-8.42%	-28.23%	-210.61%	-370.57%	-297.6%	-163.49%	19.24%	62.16%	65.03%	50.99%	5.81%	33.75%
FCF per Share	-0.95	-1.05	-0.92	-0.79	-0.86	-0.91	-1.57	-4.40	-3.22	-4.29	-6.18	-6.03	-6.50	-6.19	-3.44	-2.56	-2.33	-3.35	-6.07	-9.00
FCF Conversion (FCF/Net Income)	0.97x	0.85x	0.66x	0.79x	0.89x	0.66x	1.40x	0.97x	0.47x	0.90x	1.53x	0.91x	0.62x	0.77x	0.59x	0.57x	0.45x	0.77x	1.07x	0.66x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0